Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001415889-25-001162

Options or other derivatives

  • Director acquired 47,587 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lamond David Director 2025-01-02 Grant or award · Director Stock Option (right to buy) +47,587 47,587 D: show line 1 in the form
Loading xslF345X05/form4-01092025_120154.xml…